These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28053076)

  • 1. Opportunities to Apply the 3Rs in Safety Assessment Programs.
    Sewell F; Edwards J; Prior H; Robinson S
    ILAR J; 2016 Dec; 57(2):234-245. PubMed ID: 28053076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory Acceptance of Alternative Methods in the Development and Approval of Pharmaceuticals.
    Beken S; Kasper P; van der Laan JW
    Adv Exp Med Biol; 2016; 856():33-64. PubMed ID: 27671719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refinement, reduction, and replacement of animal use for regulatory testing: future improvements and implementation within the regulatory framework.
    Richmond J
    ILAR J; 2002; 43 Suppl():S63-8. PubMed ID: 12388854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aligning the 3Rs with new paradigms in the safety assessment of chemicals.
    Burden N; Mahony C; Müller BP; Terry C; Westmoreland C; Kimber I
    Toxicology; 2015 Apr; 330():62-6. PubMed ID: 25932488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current status of exposure-driven approaches for chemical safety assessment: A cross-sector perspective.
    Sewell F; Aggarwal M; Bachler G; Broadmeadow A; Gellatly N; Moore E; Robinson S; Rooseboom M; Stevens A; Terry C; Burden N
    Toxicology; 2017 Aug; 389():109-117. PubMed ID: 28774667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating endocrine-disrupting properties of chemicals in fish and amphibians: Opportunities to apply the 3Rs.
    Burden N; Embry MR; Hutchinson TH; Lynn SG; Maynard SK; Mitchell CA; Pellizzato F; Sewell F; Thorpe KL; Weltje L; Wheeler JR
    Integr Environ Assess Manag; 2022 Mar; 18(2):442-458. PubMed ID: 34292658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Working in partnership to advance the 3Rs in toxicity testing.
    Holmes AM; Creton S; Chapman K
    Toxicology; 2010 Jan; 267(1-3):14-9. PubMed ID: 19903508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors stimulating or obstructing the implementation of the 3Rs in the regulatory process.
    Schiffelers MJ; Blaauboer BJ; Fentener van Vlissingen JM; Kuil J; Remie R; Thuring JW; Vaal MA; Hendriksen CF
    ALTEX; 2007; 24(4):271-8. PubMed ID: 18288426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 3Rs in research: a contemporary approach to replacement, reduction and refinement.
    MacArthur Clark J
    Br J Nutr; 2018 Aug; 120(s1):S1-S7. PubMed ID: 29081302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of Consortia Recommendations for Justification of Animal Use Within Current and Future Drug Development Paradigms.
    Prior H; Monticello T; Boulifard V; Brennan FR; Kimber I
    Int J Toxicol; 2019; 38(4):319-325. PubMed ID: 31220983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal experimentation: implementation and application of the 3Rs.
    Lewis DI
    Emerg Top Life Sci; 2019 Nov; 3(6):675-679. PubMed ID: 32915219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of the 3Rs (refinement, reduction, and replacement): validation and regulatory acceptance considerations for alternative toxicological test methods.
    Schechtman LM
    ILAR J; 2002; 43 Suppl():S85-94. PubMed ID: 12388858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of organizational culture in compliance with the principles of the 3Rs.
    Brønstad A; Berg AG
    Lab Anim (NY); 2011 Jan; 40(1):22-6. PubMed ID: 21173772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refinement, Reduction, and Replacement of Animal Toxicity Tests by Computational Methods.
    Ford KA
    ILAR J; 2016 Dec; 57(2):226-233. PubMed ID: 28053075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Rodent Husbandry Refinement Opportunities through Benchmarking and Collaboration.
    Bratcher NA; Allen CM; McLahan CL; O'Connell DM; Burr HN; Keen JN; Stanislawczyk LM; Burns MA
    J Am Assoc Lab Anim Sci; 2022 Nov; 61(6):624-633. PubMed ID: 36253074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multifactorial role of the 3Rs in shifting the harm-benefit analysis in animal models of disease.
    Graham ML; Prescott MJ
    Eur J Pharmacol; 2015 Jul; 759():19-29. PubMed ID: 25823812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANIMAL WELFARE FROM MOUSE TO MOOSE--IMPLEMENTING THE PRINCIPLES OF THE 3RS IN WILDLIFE RESEARCH.
    Lindsjö J; Fahlman Å; Törnqvist E
    J Wildl Dis; 2016 Apr; 52(2 Suppl):S65-77. PubMed ID: 26845301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The era of 3Rs implementation in developmental and reproductive toxicity (DART) testing: Current overview and future perspectives.
    Beekhuijzen M
    Reprod Toxicol; 2017 Sep; 72():86-96. PubMed ID: 28552675
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.